Skewed Recommendations Due to Conflicts of Interest.
作者信息
Schott Gisela, Schurig Niklas, Dannenberg Manja, Wille Hans
出版信息
Dtsch Arztebl Int. 2019 Jun 10;116(23-24):420. doi: 10.3238/arztebl.2019.0420a.
Abstract
摘要
相似文献
1
Skewed Recommendations Due to Conflicts of Interest.因利益冲突导致的有失偏颇的建议。
Dtsch Arztebl Int. 2019 Jun 10;116(23-24):420. doi: 10.3238/arztebl.2019.0420a.
2
[Therapy of venous thromboembolisms].[静脉血栓栓塞症的治疗]
Med Klin (Munich). 2010 Sep;105(9):674; author reply 675. doi: 10.1007/s00063-010-1110-y.
3
[Current Recommendations for the Prevention and Treatment of Venous Thromboembolism in Cancer Patients].[癌症患者静脉血栓栓塞预防与治疗的当前建议]
Klin Onkol. 2017 Spring;30(2):100-105. doi: 10.14735/amko2017100.
4
Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines.根治性膀胱切除术患者的静脉血栓栓塞症延伸预防：呼吁遵循当前指南。
J Urol. 2018 Apr;199(4):906-914. doi: 10.1016/j.juro.2017.08.130. Epub 2017 Nov 4.
5
Management of venous thromboembolism in patients with cancer.癌症患者静脉血栓栓塞的管理
Br J Hosp Med (Lond). 2009 Jul;70(7):380-5. doi: 10.12968/hmed.2009.70.7.43119.
6
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.美国血液学会 2018 年静脉血栓栓塞症管理指南：妊娠相关静脉血栓栓塞症。
Blood Adv. 2018 Nov 27;2(22):3317-3359. doi: 10.1182/bloodadvances.2018024802.
7
Management of venous thromboembolism in cancer patients: ESMO clinical recommendations.癌症患者静脉血栓栓塞的管理：ESMO临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii126-7. doi: 10.1093/annonc/mdn110.
8
Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism.接受直接口服抗凝剂治疗静脉血栓栓塞症的女性出现异常子宫出血。
Vascul Pharmacol. 2017 Aug;93-95:1-5. doi: 10.1016/j.vph.2017.05.001. Epub 2017 May 4.
9
Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.评估直接口服抗凝剂治疗癌症相关性血栓：更新。
J Thromb Thrombolysis. 2019 Apr;47(3):409-419. doi: 10.1007/s11239-018-1783-2.
10
Conflicts of interest in expert-authored practice parameters, standards, guidelines, recommendations.专家撰写的实践参数、标准、指南、建议中的利益冲突。
Anesthesiology. 2010 Sep;113(3):751-2; author reply 752-3. doi: 10.1097/ALN.0b.013e3181ebdde2.
本文引用的文献
1
Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism.非维生素 K 拮抗剂口服抗凝剂（NOAC）作为肿瘤相关静脉血栓栓塞症的一种替代治疗选择。
Dtsch Arztebl Int. 2019 Jan 18;116(3):31-38. doi: 10.3238/arztebl.2019.0031.
2
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).癌症合并静脉血栓栓塞症患者中口服 Xa 因子抑制剂与低分子肝素的比较：一项随机试验（SELECT-D）的结果。
J Clin Oncol. 2018 Jul 10;36(20):2017-2023. doi: 10.1200/JCO.2018.78.8034. Epub 2018 May 10.
3
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.依度沙班治疗癌症相关静脉血栓栓塞症。
N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12.
4
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.制药公司资助药物试验及其后果。第 1 部分：对可能影响药物试验结果、方案和质量的文献进行定性、系统的回顾。
Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23.
Zotero 插件